Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota

Drug Metabolism and Disposition · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles